The Translational Genomics Research Institute
114Patents
114Active
114Granted
58Portfolio score
Filing activity: Jan 26, 2007 → Jul 20, 2022 · 9 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9797882B2 | Method of screening for a compound for inhibitory activity of FN14-tweak interaction | Physics | 11 | Active |
| US9238034B2 | FN14 antagonists and therapeutic uses thereof | Human Necessities | 11 | Active |
| US8911940B2 | Methods of assessing a risk of cancer progression | Chemistry; Metallurgy | 8 | Active |
| US9254288B2 | Susceptibility of tumors to tyrosine kinase inhibitors and treatment thereof | Physics | 8 | Active |
| US8703736B2 | Therapeutic target for pancreatic cancer cells | Chemistry; Metallurgy | 7 | Active |
| US9738717B2 | Hybridoma clones, monoclonal antibodies, and methods of use | Physics | 6 | Active |
| US9140689B2 | Methods of determining susceptibility of tumors to tyrosine kinase inhibitors | Physics | 5 | Active |
| US9125901B2 | 4-(benzimidazol-2-ylamino)benzamide derivatives and salts or solvates thereof | Chemistry; Metallurgy | 3 | Active |
| US7816082B2 | Methods of identifying pancreatic cancer cells | Chemistry; Metallurgy | 3 | Active |
| US9663826B2 | System and method of genomic profiling | Chemistry; Metallurgy | 3 | Active |
| US11406671B2 | Compositions and methods for augmenting the nasal microbiome | Human Necessities | 2 | Active |
| US8673572B2 | Methods used in identifying glioblastoma | Physics | 2 | Active |
| US11186875B2 | Targeted therapies for cancer | Physics | 2 | Active |
| US8722335B2 | Methods and kits used in the detection of fungus | Chemistry; Metallurgy | 2 | Active |
| US9434986B2 | Methods and kits used in the detection of fungus | Chemistry; Metallurgy | 1 | Active |
| US9404161B2 | Method of detecting and quantifying coccidioides species | Chemistry; Metallurgy | 1 | Active |
| US9637798B2 | Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer | Emerging Cross-Sectional Technologies | 1 | Active |
| US10993946B2 | Systems and methods for treating cancer | Human Necessities | 1 | Active |
| US8962581B2 | Methods and kits to identify invasive glioblastoma | Chemistry; Metallurgy | 1 | Active |
| US11098349B2 | Systems and methods of diagnosing and characterizing infections | Chemistry; Metallurgy | 1 | Active |
| US9221773B2 | Benzamide derivatives | Chemistry; Metallurgy | 1 | Active |
| US10449197B2 | Systems and methods for treating cancer | Human Necessities | 1 | Active |
| US9464059B2 | Benzamide derivatives | Chemistry; Metallurgy | 1 | Active |
| US10385394B2 | Processes of identifying and characterizing X-linked disorders | Chemistry; Metallurgy | 1 | Active |
| US10214782B2 | Methods and kits to identify klebsiella strains | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.